TAKARA BIO INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,060 JPY | +2.12% |
|
+4.95% | -15.34% |
| May. 10 | Takara Bio Inc. Proposes Dividend for the Fiscal Year Ending March 31, 2024, Effective June 24, 2024 | CI |
| Mar. 18 | Takara Bio Inc.(TSE:4974) dropped from FTSE All-World Index | CI |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
| Sales 2024 | 43.5B 278M | Sales 2025 * | 46.92B 300M | Capitalization | 125B 799M |
|---|---|---|---|---|---|
| Net income 2024 | 1.48B 9.46M | Net income 2025 * | 3.49B 22.32M | EV / Sales 2024 | 2.68 x |
| Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 2.66 x |
| P/E ratio 2024 |
78.9
x | P/E ratio 2025 * |
35.8
x | Employees | 1,793 |
| Yield 2024 |
1.75% | Yield 2025 * |
1.73% | Free-Float | 39.09% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | +2.12% | ||
| 1 week | +4.64% | ||
| Current month | +3.72% | ||
| 1 month | +11.11% | ||
| 3 months | -11.07% | ||
| 6 months | -10.55% | ||
| Current year | -15.34% |
1 week
1 005.00
1 073.00
1 month
937.001 073.00
Current year
931.001 290.00
1 year
931.001 790.00
3 years
931.003 350.00
5 years
931.003 535.00
10 years
900.003 535.00
| Managers | Title | Age | Since |
|---|---|---|---|
| Director of Finance/CFO | 68 | 14-05-31 | |
Koichi Nakao
PSD | President | 61 | 02-03-31 |
Takuya Kakemi
ADM | Chief Administrative Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Hisashi Omiya
CHM | Chairman | 80 | 02-03-31 |
Masanobu Kimura
BRD | Director/Board Member | 60 | 13-04-30 |
Koichi Nakao
PSD | President | 61 | 02-03-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.00% | 22 M€ | +4.08% | - | |
| 0.22% | 10 M€ | +8.50% | ||
| 0.06% | 57 M€ | +16.86% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-14 | 1,060 | +2.12% | 351 000 |
| 24-05-13 | 1,038 | +1.27% | 522,200 |
| 24-05-10 | 1,025 | +0.49% | 235,500 |
| 24-05-09 | 1,020 | +0.79% | 199,600 |
| 24-05-08 | 1,012 | -0.10% | 245,400 |
Delayed Quote Japan Exchange, May 14, 2024 at 02:00 am EDT
More quotes
TAKARA BIO INC. is a Japan-based company principally engaged in bio-industry support business and gene medicine business. The Company operates in three business segments. Bioindustry Support segment provides reagents for research (genetic engineering reagents, cell engineering reagents, protein engineering reagents), scientific instruments, contract services and license fees for gene related patents to research institutes, such as universities and companies where biotechnology research and development are conducted. Gene Medicine segment provides gene therapy-related development and sale licensing fees and trial products as an application field of genetic engineering technology and cell engineering technology which is core technology cultivated in development of research reagents. Medical Food and Biotechnology segment provides health food and health food research and development services, license fees for health food related patents, as well as license fees for mushrooms.
Calendar
2024-08-05
- Q1 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
1,038
JPY
Average target price
1,567
JPY
Spread / Average Target
+50.93%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -15.34% | 800M | |
| +26.37% | 48.16B | |
| -1.01% | 41.73B | |
| +41.70% | 41.03B | |
| -5.31% | 28.77B | |
| +9.34% | 25.59B | |
| -21.69% | 18.96B | |
| +6.23% | 12.92B | |
| +26.99% | 12.03B | |
| -3.38% | 11.77B |
- Stock Market
- Equities
- 4974 Stock
